U.S. President Donald Trump said Friday his administration is working to secure an emergency use authorization for Pfizer’s COVID-19 vaccine, which the company announced earlier in the week was 90 per cent effective in Phase 3 clinical trials.
U.S. President Donald Trump said Friday his administration is working to secure an emergency use authorization for Pfizer’s COVID-19 vaccine, which the company announced earlier in the week was 90 per cent effective in Phase 3 clinical trials.